Company Accuray Incorporated

Equities

ARAY

US0043971052

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Accuray Incorporated

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.185 ^USD	+0.23%		+2.10%	-22.79%

Apr. 25	Accuray Incorporated Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024	CI
Apr. 18	Accuray Incorporated Expands Global Training Center Network with Opening of New Facility in Genolier, Switzerland	CI

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.

Number of employees: 1,024

USD in Million	2022	Weight	2023	Weight	Delta
Oncology Systems Products 52.1 %	215	49.9 %	233	52.1 %	+8.61%
Oncology Systems Services 47.9 %	215	50.1 %	214	47.9 %	-0.36%

USD in Million	2022	Weight	2023	Weight	Delta
Europe, India, Middle East and Africa 34.8 %	135	31.3 %	156	34.8 %	+15.77%
United States 24.0 %	0	0.0 %	107	24.0 %	-
China 16.9 %	87	20.2 %	76	16.9 %	-12.85%
Japan 13.8 %	53	12.4 %	62	13.8 %	+16.09%
Asia Pacific, excluding China 7.1 %	29	6.7 %	32	7.1 %	+9.37%
Americas 3.3 %	126	29.3 %	15	3.3 %	-88.17%

Managers	Title	Age	Since
Suzanne Winter CEO	Chief Executive Officer	61	19-10-20
Ali Pervaiz DFI	Director of Finance/CFO	44	20-07-31
Frank Valentino CTO	Chief Tech/Sci/R&D Officer	-	-
G. S. Jha CTO	Chief Tech/Sci/R&D Officer	-	-
Seth Blacksburg CTO	Chief Tech/Sci/R&D Officer	-	22-09-13
Michael Hoge COO	Chief Operating Officer	-	20-02-29
Patrick Spine ADM	Chief Administrative Officer	61	18-05-06
Melanie Gebauer HRO	Human Resources Officer	-	-
Gina Corradetti AUD	Comptroller/Controller/Auditor	51	22-11-30
Sandeep Chalke PRN	Corporate Officer/Principal	-	22-05-15

Members of the board	Title	Age	Since
Beverly A. Huss BRD	Director/Board Member	64	18-01-06
Robert Kill BRD	Director/Board Member	60	23-01-29
Suzanne Winter CEO	Chief Executive Officer	61	19-10-20
Joseph Whitters CHM	Chairman	66	18-07-15
James Hindman BRD	Director/Board Member	63	19-09-05
Mika Nishimura BRD	Director/Board Member	60	21-08-16
Byron Scott BRD	Director/Board Member	61	21-02-11
Anne Le Grand BRD	Director/Board Member	73	20-07-15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	99,168,765	95,622,655 ( 96.42 %)	0	96.42 %

Name	Equities	%	Valuation
BlackRock Advisors LLC 7.993 %	7,926,428	7.993 %	20 M $
Archon Capital Management LLC 6.567 %	6,512,479	6.567 %	16 M $
LB Hercules Holdings LLC 5.541 %	5,495,414	5.541 %	14 M $
Vanguard Fiduciary Trust Co. 5.313 %	5,269,207	5.313 %	13 M $
Royce & Associates LP 3.260 %	3,233,116	3.260 %	8 M $
Renaissance Technologies LLC 2.890 %	2,865,884	2.890 %	7 M $
Heartland Advisors, Inc. 2.881 %	2,857,500	2.881 %	7 M $
Geode Capital Management LLC 2.014 %	1,997,076	2.014 %	5 M $
D.E. Shaw & Co., Inc. 1.932 %	1,915,585	1.932 %	5 M $
Harbert Fund Advisors, Inc. 1.865 %	1,849,184	1.865 %	5 M $

Accuray, Inc.

1240 Deming Way

53717, Madison

+608 824 2800

http://www.accuray.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.19 USD

Average target price

8.75 USD

Spread / Average Target

+299.54%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ACCURAY INCORPORATED	-22.79%	217M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B
RESMED, INC.	+26.76%	32.03B

Other Advanced Medical Equipment & Technology